What this means
Diabetic wound healing is severely hindered by a dysregulated microenvironment characterized by hyperglycemia, persistent infection and severe hypoxia. Herein, we designed a pathology-powered therapeutic cascade hydrogel, Gel@Lip-TEx@GCu-GOX based on a dynamic polysaccharide network.
A plain-English summary is on its way. Until then, this is the start of the authors' own summary.
- Who it was tested in
- Animals or cells
- Kind of research
- Research in animals or cells
The science
- Original title
- A tea exosome-integrated self‑oxygenating cascade chitosan/oxidized alginate hydrogel for remodeling the hyperglycemic and hypoxic microenvironment in diabetic wound healing.
- Authors
- Xie LH, Zhou XH, Wen WQ et al.
- Journal
- Carbohydrate polymers
- Published
- Aug 12, 2026
- Study type
- Lab or animal study · indexed as animal research
- PMID
- 42586657 ↗
Abstract
Diabetic wound healing is severely hindered by a dysregulated microenvironment characterized by hyperglycemia, persistent infection and severe hypoxia. Herein, we designed a pathology-powered therapeutic cascade hydrogel, Gel@Lip-TEx@GCu-GOX based on a dynamic polysaccharide network. This injectable and wound-adaptive carbohydrate polymer matrix not only provides a biocompatible scaffold for irregular wound coverage, but also enables the local retention and stabilization of a tea-exosome/liposome-integrated glucose oxidase catalytic system. Within the dynamic polysaccharide network, glucose oxidase (GOX) initiates hyperglycemia-to-antibacterial conversion by consuming excess glucose and producing antibacterial H2O2, thereby restricting bacterial proliferation and reducing nutrient availability. GHK-Cu further drives H2O2-to-O2 conversion, which prevents peroxide overload, alleviates oxidative injury, and improves the hypoxic wound microenvironment. In parallel, liposome-associated tea leaves-derived exosomes (TEx) protects GOX activity and provides plant exosome-guided immune reprogramming, shifting macrophages toward a reparative M2 phenotype and supporting angiogenesis. In vitro and in vivo studies confirmed that Gel@Lip-TEx@GCu-GOX exerted potent antibacterial activity, enhanced M2 polarization and angiogenesis, and markedly accelerated diabetic wound repair. This study therefore establishes a disease-microenvironment-driven catalytic hydrogel platform for transforming pathological diabetic wound signals into coordinated regenerative therapy.
Xie LH, Zhou XH, Wen WQ et al. A tea exosome-integrated self‑oxygenating cascade chitosan/oxidized alginate hydrogel for remodeling the hyperglycemic and hypoxic microenvironment in diabetic wound healing. Carbohydrate polymers. 2026. doi:10.1016/j.carbpol.2026.125628. PMID: 42586657. https://pubmed.ncbi.nlm.nih.gov/42586657/
Related research
Mixing a senescence-clearing drug with trametinib slowed glioma regrowth in mice
Researchers found a drug combination that cleared aging-like tumour cells in mice and slowed regrowth. This does not show the combination would work the same way in children.
Neuronal receptor remodeling in the aging periosteum: From single-cell atlases to regenerative targets.
The periosteum is the most densely innervated compartment of the skeleton and harbors periosteal stem cells expressing a broad repertoire of neuronal receptors traditionally associated with the nervous system.
Review of copper peptide GHK-Cu studies finds many lab results but few human trials
Researchers read 64 studies on GHK-Cu, a copper-linked peptide, and found much lab and animal work. They say well-designed human trials using microneedles are still needed.
A skin mix with GHK-Cu may help wrinkles and skin barrier in tests
Researchers tested a mix of a ferment extract and a copper peptide for skin aging. The results suggest it may help, but these early tests do not prove it works for everyone.
Review of a copper peptide used in skin treatments
Researchers reviewed 20 studies on GHK-Cu, a copper peptide, for skin and beauty uses. Most were lab or animal studies, and only two were human trials, so more strong testing is still needed.
Review finds GHK-Cu promising in lab and animal studies but unproven in people
Authors reviewed studies of GHK-Cu, a copper-peptide, across labs, animals, small human tests, and drug-delivery work. They say it is not yet a proven treatment for people.
See all research on Stem cell therapy →